Skip to main content
. 2018 Apr 19;23(9):1039–1053. doi: 10.1634/theoncologist.2017-0524

Table 6. Clinical trial efficacy data of new drug monotherapy.

image

Abbreviations: —, not available; ALK, anaplastic lymphoma kinase; CTCL, cutaneous T‐cell lymphoma; CR, complete remission; Cru, unconfirmed complete remission; DoR, duration of response; ORR, overall response rate; OS, overall survival; MoAb, monoclonal antibodies; NK, natural killer; PFS, progression‐free survival; PI3K, phosphoinositide‐3 kinase; PTCL, peripheral T‐cell lymphoma; Ref., reference.